market Reports

Research Report on China's Mesalazine Market, 2021-2025

SKU ID : CRI-19159374

No. of pages : 40

Publishing Date : 16-Sep-2021

Detailed TOC of Research Report on China's Mesalazine Market, 2021-2025

Table of Contents
1 Relevant Concept of Mesalazine
1.1 Indications of Mesalazine
1.2 Development of China’s Mesalazine Market
1.3 Governmental Approval of Mesalazine in China
1.4 The Impact of COVID-19 on China’s Mesalazine Market

2 Sales of Mesalazine in China, 2016-2020
2.1 Sales Value
2.1.1 Sales Value in China
2.1.2 Sales Value in China by Region
2.2 Sales Volume
2.2.1 Sales Volume in China
2.2.2 Sales Volume in China by Region
2.3 Sales of Mesalazine in China by Dosage Form, 2016-2020
2.3.1 Enteric Coated Tablets
2.3.2 Sustained-Release Granules
2.3.3 Rectal suppositories
2.3.4 Enemas
2.3.5 Prolonged-Release Tablets

3 Analysis of Major Mesalazine Manufacturers in China, 2020
3.1 Analysis of Market Share
3.1.1 Market Share of Manufacturers by Sales Value
3.1.2 Market Share of Manufacturers by Sales Volume
3.2 Dr Falk Pharma GmbH
3.2.1 Company Profile
3.2.2 Sales of Mesalazine in China
3.3 Shanghai Aidefa Pharmaceutical Co., Ltd.
3.3.1 Company Profile
3.3.2 Sales of Mesalazine in China
3.4 Ferring Arzneimittel GmbH
3.4.1 Company Profile
3.4.2 Sales of Mesalazine in China
3.5 Sunflower Pharmaceutical Group Jiamusi Luling Pharmaceutical Co., Ltd.
3.5.1 Company Profile
3.5.2 Sales of Mesalazine in China
3.6 Heilongjiang Tianhong Pharmaceutical Co., Ltd.

4 Sales Price of Mesalazine of Different Companies in China, 2020-2021
4.1 Dr Falk Pharma GmbH (Salofalk®)
4.2 Shanghai Aidefa Pharmaceutical Co., Ltd. (Aidisha®)
4.3 Ferring Arzneimittel GmbH (PENTASA®)
4.4 Sunflower Pharmaceutical Group Jiamusi Luling Pharmaceutical Co., Ltd. (Huidi®)
4.5 Heilongjiang Tianhong Pharmaceutical Co., Ltd. (Meishaxin®)

5 Prospects of China’s Mesalazine Market, 2021-2025
5.1 Influencing Factors for the Market Development
5.1.1 The Impact of COVID-19 on the Market
5.1.2 Market Drivers and Opportunities
5.1.3 Market Threats and Challenges
5.2 Forecast on Market Size
5.3 Forecast on Market Trend

List of Charts
Chart Patent Information of Mesalazine in China
Chart Sales Value of Mesalazine in China, 2016-2020
Chart Sales Volume of Mesalazine in China, 2016-2020
Chart Sales Volume of Mesalazine in China by Region, 2016-2020
Chart Sales Value of Mesalazine in China by Region, 2016-2020
Chart Sales Value and Volume of Mesalazine Enteric Coated Tablets in China, 2016-2020
Chart Sales Value and Volume of Mesalazine Sustained-Release Granules in China, 2016-2020
Chart Sales Value and Volume of Mesalazine Prolonged-Release Tablets in China, 2016-2020
Chart Market Share of Mesalazine Manufacturers in China by Sales Value, 2016-2020
Chart Sales Value and Volume of Mesalazine (of Dr Falk Pharma GmbH) in China, 2016-2020
Chart Sales Value and Volume of Mesalazine (of Shanghai Aidefa Pharmaceutical Co., Ltd.) in China, 2016-2020
Chart Sales Price of Salofalk (Mesalazine of Dr Falk Pharma GmbH) in China by Region, 2020
Chart Sales Price of Aidisha (Mesalazine of Shanghai Aidefa Pharmaceutical Co., Ltd.) in China by Region, 2020
Chart Forecast on Sales Value of Mesalazine in China, 2021-2025
Chart Forecast on Sales Volume of Mesalazine in China, 2021-2025

Keyplayers in Research Report on China's Mesalazine Market, 2021-2025

1 Dr Falk Pharma GmbH (Salofalk®)
2 Shanghai Aidefa Pharmaceutical Co., Ltd. (Aidisha®)
3 Ferring Arzneimittel GmbH (PENTASA®)
4 Sunflower Pharmaceutical Group Jiamusi Luling Pharmaceutical Co., Ltd. (Huidi®)
5 Heilongjiang Tianhong Pharmaceutical Co., Ltd. (Meishaxin®)
market Reports market Reports